Advertisement

Topics

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

2018-08-20 19:52:14 | BioPortfolio

Published on BioPortfolio: 2018-08-20T19:52:14-0400

Clinical Trials [1336 Associated Clinical Trials listed on BioPortfolio]

Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With TBI and MCI

The experimental design is an open-label two-week trial of tolcapone to evaluate which clinical domains are affected by tolcapone treatment and to identify "responders" to tolcapone treatm...

Tolcapone in Obsessive Compulsive Disorder

The proposed study will consist of a 5-week double-blind cross-over study trial of tolcapone in 20 people (ages 18-65). The study will be divided into an initial 2 week phase and a second ...

Trial of Tolcapone With Oxaliplatin for Neuroblastoma or Medulloblastoma

The purpose of this research study is to evaluate an investigational drug (Tolcapone) alone and in combination with oxaliplatin, for relapsed and refractory neuroblastoma and medulloblasto...

Tolcapone Treatment of Pathological Gambling

The goal of the proposed study is to evaluate the efficacy and safety of tolcapone in pathological gambling.

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.

PubMed Articles [12873 Associated PubMed Articles listed on BioPortfolio]

METABOLISM AND ELIMINATION OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE IN THE HORSE.

The metabolism of the masking agent tolcapone in the horse has been investigated. This substance was found to have undergone various chemical transformations that produced a large variety of phase I m...

Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs.

Human aldehyde oxidase 1 (AOX1) catalyzes the oxidation of various drugs and endogenous compounds. Recently, we found that AOX1 catalyzed the reduction of drugs such as nitrazepam and dantrolene. In t...

Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.

Trimetazidine (TMZ) is an anti-ischemic metabolic agent that has been shown to be efficacious in angina treatment, both in monotherapy and in combination. A new formulation of TMZ modified-release (MR...

A comparison of single-dose and multiple divided daily-dose oral steroids for sudden sensorineural hearing loss.

Glucocorticoids are considered the first-line therapy for sudden sensorineural hearing loss. But there is currently no consensus on administering them as a single dose versus multiple divided daily do...

Biological and Mechanical Evaluation of Novel Prototype Dental Composites.

The breakdown of the polymeric component of contemporary composite dental restorative materials compromises their longevity, while leachable compounds from these materials have cellular consequences. ...

Medical and Biotech [MESH] Definitions

A treatment schedule in which the total dose of radiation is divided into large doses.

The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population.

Food derived from genetically modified organisms (ORGANISMS, GENETICALLY MODIFIED).

A ubiquitous target SNARE protein that interacts with SYNTAXIN and SYNAPTOBREVIN. It is a core component of the machinery for intracellular MEMBRANE FUSION. The sequence contains 2 SNARE domains, one is the prototype for the Qb-SNARES, and the other is the prototype for the Qc-SNARES.

The highest dose of a biologically active agent given during a chronic study that will not reduce longevity from effects other than carcinogenicity. (from Lewis Dictionary of Toxicology, 1st ed)

More From BioPortfolio on "A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial